Mena FN

The Langdon Center Now Offers Qwo®, the First FDA-Approved Injectable Cellulite Treatment

(MENAFN- GetNews) The Accreditation Association for Ambulatory Health Care designates The Langdon Center as an excellent organization that exceeds its standards for patient safety. Guilford, CT – The ...
FiercePharma

Troubled Endo shelves cellulite treatment Qwo, lays off 90 employees

Just nine months after launching its “Butt First” campaign—designed to spark sales of its groundbreaking cellulite treatment—troubled Endo has pulled the plug on Qwo (collagenase clostridium ...
Nasdaq

Butt First: Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostridium histolyticum-aaes) With 200+ Patient Events

DUBLIN, March 2, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) has kicked off a series of more than 200 patient events that will be held across the United States as part of Butt First, a ...
The Business Journals

Qwo gets 'Butt First' blitz as Endo looks to generate buzz for its injectable cellulite treatment

A beach shot Endo is using as part of its "Butt First" campaign to educate people about cellulite and promote its cellulite treatment Qwo. Endo International has selected a unique moniker for its ...
Business Insider

Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting

DUBLIN, May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the upcoming launch of a new clinical study relevant to the use of Qwo ® (collagenase clostridium histolyticum ...